Posted by Michael Wonder on 10 Sep 2023
European Commission expands Merck’s Ervebo [Ebola Zaire vaccine, live] indication to include children 1 year of age and older
7 September 2023 - Milestone signifies on-going effort to help prepare for outbreaks of Zaire ebolavirus.
Merck announced today that the European Commission has approved an expanded indication for Ervebo for active immunization of individuals 1 year of age or older to protect against Ebola virus disease caused by Zaire ebolavirus.
